Effects of Intraperitoneal Mitomycin C Adsorbed on Activated Carbon on Adhesion Formation and Mesothelial Cells In Vitro
Objective: To investigate the incidence of adhesions after intraperitoneal instillation of mitomycin C adsorbed on activated carbon (MMC-CH). Design: Animal and laboratory studies. Setting: University hospital, Germany. Animals: 90 Sprague-Dawley rats. Interventions: Laparotomy, small bowel anastomo...
Gespeichert in:
Veröffentlicht in: | The European journal of surgery 2000, Vol.166 (7), p.572-576 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective: To investigate the incidence of adhesions after intraperitoneal instillation of mitomycin C adsorbed on activated carbon (MMC-CH).
Design: Animal and laboratory studies.
Setting: University hospital, Germany.
Animals: 90 Sprague-Dawley rats.
Interventions: Laparotomy, small bowel anastomosis, and intraperitoneal instillation of saline (controls, n = 27), activated carbon alone (n = 24) or MMC-CH (n = 26). Cultures of monolayers of human mesothelial cells.
Main outcome measures: Measurements of adhesions by planimetry. Toxicity of mitomycin C alone and charcoal alone in mesothelial cell monolayers as reflected by cell proliferation and measurement of lactate dehydrogenase activity. Concentrations of plasminogen activator (tPA) and plasminogen activator inhibitor 1 (PAI-1) as measures of the fibrinolytic activity of mesothelial cells.
Results: Both activated carbon and MMC-CH caused a significant increase of adhesion formation in rats. Activated carbon also reduced the fibrinolytic activity of mesothelial cells, and mitomycin C caused concentration-dependent cytotoxicity in vitro.
Conclusions: Activated carbon combined with high concentrations of mitomycin C may cause intraperitoneal infective complications by increasing the rate of adhesion formation and reducing the fibrinolytic activity of mesothelial cells. We recommend a new absorbable carrier for intraperitoneal chemotherapy. |
---|---|
ISSN: | 1102-4151 1741-9271 |
DOI: | 10.3109/110241500750008664 |